SCHEMBL29802932

SCHEMBL29802932

Cn1cc2c(Cl)c(S)ccc2n1.[Na]

nearest known ligand 0.36

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ PTPN11 Q06124 16/20 0.36
▸ ADORA2A P29274 1/20 0.34
▸ ADORA1 P30542 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ NSD2 O96028 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24879337 0.98 PTPN11 (0.36) PTPN11ADORA2AADORA1KDM4ENSD2
SCHEMBL28627313 0.96 PTPN11 (0.35) PTPN11ADORA2AADORA1KDM4ENSD2
SCHEMBL21631652 0.80 PTPN11 (0.36) PTPN11ADORA2AADORA1KDM4ENSD2
SCHEMBL23508730 0.78 PTPN11 (0.37) PTPN11ADORA2AADORA1KDM4ENSD2
SCHEMBL21653696 0.76 ADORA2A (0.42) PTPN11ADORA2AADORA1KDM4ENSD2
SCHEMBL26156073 0.76 PTPN11 (0.36) PTPN11ADORA2AADORA1KDM4ENSD2
SCHEMBL21631725 0.75 ADORA2A (0.38) PTPN11ADORA2AADORA1ALDH1A1MAPT
SCHEMBL26920421 0.75 PTPN11 (0.35) PTPN11ADORA2AADORA1KDM4ENSD2
SCHEMBL24858186 0.74 MET (0.35) PTPN11ADORA2AADORA1KDM4ENSD2
SCHEMBL28889827 0.74 PTPN11 (0.36) PTPN11ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120129683-A Azole derivatives as SHP2 inhibitors IRBM股份公司 2025-06-10 — — CN disclosed
CN-114981268-B Pyrimidine-4 (3H) -ketone heterocyclic compound, preparation method and application thereof in medicine 北京诺诚健华医药科技有限公司 2025-01-28 — — CN disclosed
CN-114981268-A Pyrimidine-4 (3H) -ketone heterocyclic compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2022-08-30 — — CN disclosed
Send feedback